Table 1 Patient characteristics, outcome and genetic information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |
|---|---|---|---|---|---|---|---|---|
Age | 27 | 32 | 22 | 32 | 22 | 29 | 48 | 39 |
Histology | DCIS | IDC and DCIS | IDC | IDC | Phyllodes sarcoma | IDC | IDC | DCIS |
Grade | NA | 1 | NA | 2 | NA | 2 | 3 | NA |
Hormonal receptor | UN | pos | pos | pos | NA | pos | pos | pos |
HER2 overexpression | NA | neg | pos | pos | NA | neg | neg | NA |
TNM | TisN0M0 | T1N0M0 | T2N1M0 | T1N1M0 | TxN0M0 | T1N1M0 | T4N1M0 | TisN0M0 |
Adjuvant Radiotherapy | No | No | Yes | Yes | Yes | Yes | Yes | Yes |
Local relapse | No | No | No | No | Yes | Yes | No | Yes |
Contralateral breast cancer | No | Yes | No | Yes | Yes | Yes | No | No |
Radio induced tumors | No | No | No | No | Yes | No | * | Yes |
New primary outside RT field | No | No | No | No | Yes | No | No | Yes |
Codon Mutation | c.375G > C exon 4 splice site | c.844C > T exon 8 missense | c.742C > T exon 7 missense | c.467G > A exon 5 missense | c.724T > C exon 7 missense | c.542G > A exon 5 missense | c.524G > A exon 5 missense | c.673-2A > G intron 6 splice site |